ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2024 Earnings Call Transcript July 29, 2024
Operator: Good morning, ladies and gentlemen, and thank you for joining us today for the ImmunoPrecise Antibodies Fourth Quarter and Fiscal Year-End 2024 Earnings Call. Today’s call will be led by our CEO, Dr. Jennifer Bath, and our CFO, Kristin Taylor. Please note that a copy of today’s presentation, along with our financial statements will be available on IPA’s company website for your reference. We...
